| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.45 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |